SCHEMBL22566239

SCHEMBL22566239

Cc1ncc2c(n1)C(=O)N(C1CCC(=O)NC1=O)C2=O

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.57
▸ DDB1 Q16531 12/20 0.57
▸ IKZF3 Q9UKT9 2/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ CHRM2 P08172 1/20 0.57
▸ OPRM1 P35372 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ TNF P01375 2/20 0.48
▸ IL1B P01584 1/20 0.48
▸ TBXA2R P21731 1/20 0.48
▸ IKZF1 Q13422 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22566217 0.81 CRBN (0.62) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22297288 0.81 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22566237 0.81 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22566235 0.80 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL17169677 0.80 CRBN (0.59) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22566227 0.80 CRBN (0.61) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20231888 0.79 CRBN (0.50) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22566222 0.79 CRBN (0.51) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL17169675 0.77 CRBN (0.62) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22566220 0.77 CRBN (0.52) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 — — WO disclosed
EP-3971176-A1 AROMATIC AMINE AR AND BET TARGETING PROTEIN DEGRADATION CHIMERA COMPOUND AND USE Hinova Pharmaceuticals Inc. (CN) 2022-03-23 — — EP disclosed
WO-2020211822-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF 成都海创药业有限公司 2020-10-22 — — WO disclosed
Send feedback